Rare diseases
Investigational molecules
Locations
Back to Denmark103 clinical trials in Esbjerg, Denmark across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)Study on MK-0616 for Reducing Heart Disease Events in Patients with Atherosclerotic Cardiovascular Disease
DenmarkStudy on Long-Term Safety of Tolebrutinib for Patients with Relapsing or Progressive Multiple Sclerosis
DenmarkStudy Comparing R-MINI-CHOP and R-MINI-CHP with Polatuzumab Vedotin for Treating Diffuse Large B-Cell Lymphoma in Patients Aged 80 and Older or Frail Patients Aged 75 and Older
DenmarkA study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)
DenmarkStudy of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease
DenmarkStudy on the Effectiveness and Safety of JNJ-77242113 for Patients with Active Psoriatic Arthritis Who Have Not Used Biologic Treatments
DenmarkStudy on the Effects of Pelacarsen on Heart Disease in Patients with Cardiovascular Conditions
DenmarkStudy of Fezolinetant for Hot Flashes in Women with Hormone Receptor-Positive Breast Cancer Receiving Hormone Therapy
DenmarkStudy of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke
DenmarkStudy on Baxdrostat and Dapagliflozin for Adults with Chronic Kidney Disease and High Blood Pressure
DenmarkStudy of Olezarsen (ISIS 678354) in Patients with Severe Hypertriglyceridemia: Testing Effects on Triglyceride Levels
DenmarkStudy of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
DenmarkThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on heart failure prevention and innovative treatments for cardiovascular diseases. Research includes evaluation of new drug combinations and therapies for reducing major cardiac events.
Novel approaches in treating various cardiac conditions with emphasis on preventive care and therapeutic innovations.
Clinical investigations into multiple sclerosis and inflammatory conditions, including studies of new biological therapies and treatment optimization for chronic conditions.
Comprehensive research focusing on improving patient outcomes through targeted therapies.
Studies addressing obesity management and metabolic disorders, with innovative approaches to weight reduction and metabolic health improvement.
Advanced therapeutic strategies combining medication with lifestyle interventions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
